Opportunity Radar

← Back to search

Grant forecast

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

View on Grants.gov ↗ Sign in to save

Type
Grant forecast
Notice type
G
Agency
National Institutes of Health
Sub-agency
HHS-NIH11
Solicitation #
RFA-RM-28-017
Posted
Sep 14, 2026
Response due
Jul 1, 2027
CFDA / Assistance listing
93.310
Contact
SMaHT Program · smaht@od.nih.gov · Please contact via e-mail.
Source
Grants.gov

Description

The purpose of the Somatic Mosaicism across Human Tissues (SMaHT) Network is to advance discovery of biological processes and disease mechanisms mediated by somatic mutations in human tissues. Since 2023, the program has generated multi-omic somatic mutation datasets from standardized human tissues spanning all three germ layers. Building on the Stage 1 foundation, the NIH intends to issue a Notice of Funding Opportunity (NOFO)supporting Stage 2 of the SMaHT Experimental and Computational Technology Development initiative. The Experimental and Computational Technology Development initiative supports multidisciplinary development, optimization, validation, benchmarking, and dissemination of rigorous, cost-effective technologies for somatic mutation detection and functional interpretation.Awardees will collaborate with other SMaHT Stage 2 initiatives to incorporate validated technologies into production workflows, pipelines, data releases, and community resources.

Similar open opportunities